157 related articles for article (PubMed ID: 10638947)
1. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia.
Kamper EF; Papaphilis AD; Angelopoulou MK; Kopeikina LT; Siakantaris MP; Pangalis GA; Stavridis JC
Clin Biochem; 1999 Nov; 32(8):639-45. PubMed ID: 10638947
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
[TBL] [Abstract][Full Text] [Related]
3. The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis.
Kamper EF; Kopeikina LT; Trontzas P; Potamianou A; Tsiroglou E; Stavridis JC
J Rheumatol; 2000 Nov; 27(11):2545-50. PubMed ID: 11093432
[TBL] [Abstract][Full Text] [Related]
4. [Circulating adhesion molecules (cICAM-1, lcVCAM-1) in patients with suspected inflammatory heart muscle disease].
Klein RM; Breuer R; Mundhenke M; Schwartzkopff B; Strauer BE
Z Kardiol; 1998 Feb; 87(2):84-93. PubMed ID: 9556870
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome.
Fayad L; Keating MJ; Reuben JM; O'Brien S; Lee BN; Lerner S; Kurzrock R
Blood; 2001 Jan; 97(1):256-63. PubMed ID: 11133769
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.
Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
[TBL] [Abstract][Full Text] [Related]
11. Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis.
Kara IO; Sahin B; Gunesacar R
Adv Ther; 2007; 24(1):29-40. PubMed ID: 17526459
[TBL] [Abstract][Full Text] [Related]
12. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse.
Rieckmann P; Martin S; Weichselbraun I; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Helwig A
Neurology; 1994 Dec; 44(12):2367-72. PubMed ID: 7527508
[TBL] [Abstract][Full Text] [Related]
13. Expression on leukemic cells and serum circulating levels of intercellular adhesion molecule-1 (ICAM-1) in B-cell chronic lymphocytic leukemia: implications for prognosis.
Molica S; Dattilo A; Mannella A; Levato D; Levato L
Leuk Res; 1995 Aug; 19(8):573-80. PubMed ID: 7658704
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
[TBL] [Abstract][Full Text] [Related]
15. Expression of subtypes of interleukin-17 ligands and receptors in patients with B-cell chronic lymphocytic leukemia.
Garley M; Jabłońska E; Sawicka-Powierza J; Ratajczak-Wrona W; Kłoczko J; Piszcz J
Clin Lab; 2014; 60(10):1677-83. PubMed ID: 25651714
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
17. Levels of circulating intercellular adhesion molecule-1 in patients with metastatic cancer of the prostate and benign prostatic hyperplasia.
Wolff JM; Stephenson RN; Chisholm GD; Habib FK
Eur J Cancer; 1995; 31A(3):339-41. PubMed ID: 7540402
[TBL] [Abstract][Full Text] [Related]
18. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
[TBL] [Abstract][Full Text] [Related]
19. [Serum levels of soluble CD(23) and thrombopoietin in chronic lymphocytic leukemia].
Yu H; Xu W; Shen QD
Zhonghua Nei Ke Za Zhi; 2008 Oct; 47(10):826-9. PubMed ID: 19080142
[TBL] [Abstract][Full Text] [Related]
20. Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis.
Voskuyl AE; Martin S; Melchers L; Zwinderman AH; Weichselbraun I; Breedveld FC
Br J Rheumatol; 1995 Apr; 34(4):311-5. PubMed ID: 7540479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
